CD274 and neoplasm: The immune checkpoint receptor PD1 expressed on T cells binds to PD-L1 in tumor cells, resulting in T cell dysfunction by reducing T cell receptor signaling pathways, cytokine production, cell migration, and promoting T cell differentiation into Tregs.[65–67]